Ferroptosis and its interaction with tumor immune microenvironment in liver cancer

Yilan Huang1, Siwei Wang2, Aiwu Ke1

  • 1Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, Shanghai, China.

Insights

Targeting ferroptosis, a novel cell death pathway, offers a promising strategy for liver cancer treatment by directly killing cancer cells and enhancing immunotherapy effectiveness. This approach addresses challenges in systemic treatment for liver cancer.

Area of Science:

  • Oncology
  • Cell Death Research
  • Immunotherapy

Background:

  • Liver cancer remains a significant global health challenge with limited effective systemic treatments.
  • Ferroptosis, a regulated cell death pathway, is gaining attention for its potential in cancer therapy.
  • Targeting ferroptosis presents a promising strategy for overcoming treatment resistance in liver cancer.

Purpose of the Study:

  • To review the current understanding of iron homeostasis in the liver and its link to liver carcinogenesis.
  • To explore the role of ferroptosis regulators in liver cancer development.
  • To discuss the interplay between ferroptosis and the tumor immune microenvironment for potential immunotherapy applications.

Main Methods:

  • Literature review of studies on iron metabolism, ferroptosis, and liver cancer.
  • Analysis of the association between imbalanced iron homeostasis and ferroptosis in liver cancer.
  • Examination of ferroptosis-related regulators and their impact on liver cancer.

Main Results:

  • Imbalanced iron homeostasis is intrinsically linked to ferroptosis in liver carcinogenesis and progression.
  • Ferroptosis induction can directly eliminate liver cancer cells.
  • Ferroptosis can modulate the tumor immune microenvironment, enhancing sensitivity to immunotherapy.

Conclusions:

  • Ferroptosis is a viable therapeutic strategy for liver cancer, offering dual benefits of direct tumor cell killing and immune microenvironment modulation.
  • Further research into ferroptosis regulators and their interaction with the immune system holds significant potential for advancing liver cancer immunotherapy.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
629
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K